AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Endocrinology and metabolism clinics of North America

Results: 1-25/315
HOEG,JEFFREY,M., MD - IN-MEMORIAM
Authors: BREWER HB
Citation: Hb. Brewer, HOEG,JEFFREY,M., MD - IN-MEMORIAM, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 3-4
LIPID DISORDERS - PREFACE
Authors: HOEG JM
Citation: Jm. Hoeg, LIPID DISORDERS - PREFACE, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 13-14
LIPOPROTEIN PHYSIOLOGY
Authors: GINSBERG HN
Citation: Hn. Ginsberg, LIPOPROTEIN PHYSIOLOGY, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 503
GENETICS OF LIPOPROTEIN DISORDERS
Authors: DAVIGNON J GENEST J
Citation: J. Davignon et J. Genest, GENETICS OF LIPOPROTEIN DISORDERS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 521
THE FAMILIAL CHYLOMICRONEMIA SYNDROME
Authors: SANTAMARINAFOJO S
Citation: S. Santamarinafojo, THE FAMILIAL CHYLOMICRONEMIA SYNDROME, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 551
LIPOPROTEINS AND ATHEROGENESIS
Authors: HOEG JM
Citation: Jm. Hoeg, LIPOPROTEINS AND ATHEROGENESIS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 569
CLINICAL-TRIALS OF REDUCING LOW-DENSITY-LIPOPROTEIN CONCENTRATIONS
Authors: RIFKIND BM
Citation: Bm. Rifkind, CLINICAL-TRIALS OF REDUCING LOW-DENSITY-LIPOPROTEIN CONCENTRATIONS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 585
DETECTION AND EVALUATION OF DYSLIPOPROTEINEMIA
Authors: CLEEMAN JI
Citation: Ji. Cleeman, DETECTION AND EVALUATION OF DYSLIPOPROTEINEMIA, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 597
DYSLIPOPROTEINEMIA AND DIABETES
Authors: GARG A
Citation: A. Garg, DYSLIPOPROTEINEMIA AND DIABETES, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 613
WOMEN, DYSLIPOPROTEINEMIA, AND ESTROGENS
Authors: LAROSA JC
Citation: Jc. Larosa, WOMEN, DYSLIPOPROTEINEMIA, AND ESTROGENS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 627
EVALUATION AND MANAGEMENT OF DYSLIPOPROTEINEMIA IN CHILDREN
Authors: FRANKLIN FA DASHTI N FRANKLIN CC
Citation: Fa. Franklin et al., EVALUATION AND MANAGEMENT OF DYSLIPOPROTEINEMIA IN CHILDREN, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 641
THE ROLE OF CHOLESTEROL MANAGEMENT IN CORONARY-DISEASE RISK REDUCTIONIN ELDERLY PATIENTS
Authors: GRUNDY SM
Citation: Sm. Grundy, THE ROLE OF CHOLESTEROL MANAGEMENT IN CORONARY-DISEASE RISK REDUCTIONIN ELDERLY PATIENTS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 655
DRUGS CAUSING DYSLIPOPROTEINEMIA
Authors: DONAHOO WT KOSMISKI LA ECKEL RH
Citation: Wt. Donahoo et al., DRUGS CAUSING DYSLIPOPROTEINEMIA, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 677
FACTORS AFFECTING HIGH-DENSITY-LIPOPROTEINS
Authors: GORDON DJ
Citation: Dj. Gordon, FACTORS AFFECTING HIGH-DENSITY-LIPOPROTEINS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 699
DIET, LIPOPROTEINS, AND CORONARY HEART-DISEASE
Authors: SCHAEFER EJ BROUSSEAU ME
Citation: Ej. Schaefer et Me. Brousseau, DIET, LIPOPROTEINS, AND CORONARY HEART-DISEASE, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 711
OSTEOPOROSIS - PREFACE
Authors: WATTS NB
Citation: Nb. Watts, OSTEOPOROSIS - PREFACE, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 11-12
PATHOPHYSIOLOGY OF OSTEOPOROSIS
Authors: HEANEY RP
Citation: Rp. Heaney, PATHOPHYSIOLOGY OF OSTEOPOROSIS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 255
APPLICATIONS OF BONE DENSITOMETRY FOR OSTEOPOROSIS
Authors: BLAKE GM FOGELMAN I
Citation: Gm. Blake et I. Fogelman, APPLICATIONS OF BONE DENSITOMETRY FOR OSTEOPOROSIS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 267
RISK-FACTORS FOR OSTEOPOROTIC FRACTURE
Authors: ROSS PD
Citation: Pd. Ross, RISK-FACTORS FOR OSTEOPOROTIC FRACTURE, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 289
BIOCHEMICAL MARKERS OF BONE TURNOVER - APPLICATIONS FOR OSTEOPOROSIS
Authors: GARNERO P DELMAS PD
Citation: P. Garnero et Pd. Delmas, BIOCHEMICAL MARKERS OF BONE TURNOVER - APPLICATIONS FOR OSTEOPOROSIS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 303
SECONDARY OSTEOPOROSIS - DIAGNOSTIC CONSIDERATIONS
Authors: HARPER KD WEBER TJ
Citation: Kd. Harper et Tj. Weber, SECONDARY OSTEOPOROSIS - DIAGNOSTIC CONSIDERATIONS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 325
OSTEOPOROSIS IN MEN
Authors: ORWOLL ES
Citation: Es. Orwoll, OSTEOPOROSIS IN MEN, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 349
THE ROLES OF EXERCISE AND FALL RISK REDUCTION IN THE PREVENTION OF OSTEOPOROSIS
Authors: HENDERSON NK WHITE CP EISMAN JA
Citation: Nk. Henderson et al., THE ROLES OF EXERCISE AND FALL RISK REDUCTION IN THE PREVENTION OF OSTEOPOROSIS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 369
THE ROLES OF CALCIUM AND VITAMIN-D IN THE PREVENTION OF OSTEOPOROSIS
Authors: REID IR
Citation: Ir. Reid, THE ROLES OF CALCIUM AND VITAMIN-D IN THE PREVENTION OF OSTEOPOROSIS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 389
THE ROLE OF ESTROGEN IN THE PREVENTION OF OSTEOPOROSIS
Authors: LINDSAY R
Citation: R. Lindsay, THE ROLE OF ESTROGEN IN THE PREVENTION OF OSTEOPOROSIS, Endocrinology and metabolism clinics of North America, 27(2), 1998, pp. 399
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>